GOVERNANCE

  EXECUTIVE COMMITTEE

The Executive Committee is responsible for the definition of the overall company strategy. The committee takes decisions regarding development plans and defines priorities with the guidance of operational teams. Its role is also to review and validate financial topics.

Jerome-Theron

Jérôme Théron

Co-founder and CEO of Vectans Pharma

Jérôme Théron is graduated from the Helsinki School of Economics (MBA) and from Burgundy School of Business (Dijon, France).

For the past 20 years, he has been entrusted responsibilities in communication, marketing, sales and executive management of several companies at the national and international levels, such as GSK, Pfizer, Danone and Santé Verte. He co-founded the pharmaceutical promotion company Dynapharm in 2001 and the LNC Therapeutics R&D company in 2010. Vectans Pharma is his third entrepreneurial venture in the healthcare industry.

Herve-Chambournac

Hervé Cambournac

Member of the executive committee and Chief Financial Officer

Hervé Cambournac holds a Master's degree in Economics from Paris Dauphine University and an Executive MBA from HEC Paris.

Hervé first started his career at Johnson & Johnson. Then, he held various operating and financial positions at Abbott, from 1982 to 1996. Hervé was then Deputy General Manager and Group C.F.O at Baccarat until 2015. Today, Hervé Cambournac is a shareholder, member of the executive committee of Vectans Pharma and CFO.

Christiane-Bober

Christiane Bober

Member of the executive committee and Quality, Industrial & Regulatory Affairs Director

Christiane Bober holds a Pharmacy degree from Louis Pasteur University (Strasbourg I). She also graduated from University of Manitoba (Canada) with a Master of Science in Parasitology.

Her expertise in Regulatory Affairs, Quality Assurance and Industrial matters was developed through various positions, in RA, QA and as Responsible Pharmacist, held in French and international companies, such as Allergan, Procter & Gamble Pharmaceuticals, Novartis Santé Familiale, Medtronic, Laboratoires Expanscience, PTC Therapeutics.
Today, Christiane Bober is a member of the Executive Committee of Vectans Pharma.

Stefan-Lempereur

Stefan Lempereur

Member of the executive committee and Chief Medical Officer

Stefan Lempereur is a Medical Doctor who graduated from the University of Liège in Belgium.

He has a strong professional background in Medical Affairs with more than 25 years of experience in the pharmaceutical industry at national and international levels, mainly With Ipsen, but also with HRA Pharma and as an independent. Stefan Lempereur M.D. joined Vectans Pharma in March 2018, as Chief Medical Officer.

  SUPERVISORY BOARD

The board evaluates all the strategic decisions and monitors its implementation.

Patrice-Layrac

Patrice Layrac

Chairman of the Supervisory Board

Patrice Layrac holds of a PhD in Management from Paris Dauphine University , a master in Business and Finance from Sciences Po Paris and an MBA from INSEAD.

CEO of Sanofi Turkey between 1989 and 2004, he has held the position of CEO of Sanofi Belgium from 2004 to 2006, Sanofi Russia from 2006 to 2008 and Sanofi Portugal from 2008 to 2010.Patrice Layrac is co-founder and director of two pharmaceutical startups: Gen.Orph and Accense. In September 2017, he became Chairman of the Supervisory Board of Vectans Pharma.

Gerard-Leduc

Gérard Leduc

Member of the Supervisory Board

Gérard Leduc holds master degrees in physical and chemical sciences from the Ecole Nationale Supérieure de Chimie (Strasbourg).

He also graduated from the Institut du Commerce International with a degree in management. He began his career in 1971 as a trademark and patent attorney after graduating from the Centre d’Etudes Internationales de la Propriété Intellectuelle (CEIPI) and qualifying as a Professional Representative before the European Patent Office. He co-founded Ethypharm in 1977, he has been Vice Chairman of the Supervisory Board for Ethypharm S.A. He served as Chairman of Ethypharm in Shanghai, in Canada and in US. Today, he is member of the Supervisory Board of Vectans Pharma.

Etienne-Jacob

Etienne Jacob

Member of the Supervisory Board

Etienne Jacob is a graduate of the Pitie Salpetrière Faculty of Medecine (Paris), with an obstetrics and gynecology Ph.D.

He is the former SVP Europe Actelion and SVP Europe Sanofi. Since 2014, he has been Gen.Orph and Accense Pharma CEO.

Jean-Theron

Jean Théron

Co-founder of Vectans Pharma and member of the Supervisory Board

Jean Théron was at the head of the German chemicals and pharmaceuticals group Hoechst Marion Roussel France after managing several group subsidiaries.

He co-founded the French innovative biotech company Bio-Alliance Pharma (ONXEO) in 1997. Since 2002, he has been the co-founder and CEO of Imedial, a pharmaceutical promotion company. In 2012, he also became a board member of OSE Immunotherapeutics.

  ADVISORY BOARD

Pascal-Douek

Pascal Douek

Member of the Advisory Board

Graduate of the Paris VII Faculty of Medicine in Biology and Sports Medicine, Pascal Douek began his professional career as a health advertising copywriter.

Then, he became Sales Director of Torrent Healthworld and CEO of France1 Communication. Between 2001 and 2007, he was the President of Vivactis Conseil. In 2015, he obtained a University Diploma in Food Nutrition Micro Nutrition at the Faculty of Medicine of Dijon, then he specialized in longevity in the Institut Pasteur of Lille. Since May 2010, he is President at DDB Health, a communication agency specialized in health.

Paul-Belnat

Paul Belnat

Member of the Advisory Board

Paul Belnat holds a Ph.D. in Sciences, Pharmacy and Molecular Pharmacology from Paris XI University and Paris VI.

He obtained a Diploma of Advanced Studies specialized in Pharmaceutical Business Administration. He held several management positions in many companies such as B.Braun Group, Jouveinal, Sanofi, ICI Pharma, Pfizer, Carveteam, Bouchara Recordati, Ipsen Eastern Europe. Since 2014 he is CEO of Curaden France as well president at Advice Unlimited, a business consulting firm.